{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T15:57:35Z","timestamp":1713974255326},"reference-count":12,"publisher":"Massachusetts Medical Society","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2019,5,23]]},"DOI":"10.1056\/nejmc1903821","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T21:12:54Z","timestamp":1558559574000},"page":"2072-2074","source":"Crossref","is-referenced-by-count":1,"title":["Omadacycline for Bacterial Infections"],"prefix":"10.1056","volume":"380","member":"150","reference":[{"key":"e_1_2_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800201"},{"key":"e_1_2_3_2_3_2","unstructured":"Legionella (Legionnaires\u2019 disease and Pontiac fever): case definitions. Atlanta: Centers for Disease Control and Prevention 2010 (https:\/\/www.cdc.gov\/legionella\/health-depts\/surv-reporting\/case-definitions.html)."},{"key":"e_1_2_3_2_4_2","unstructured":"Commission Implementing Decision (EU) 2018\/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. 3.22. Legionnaires\u2019 disease. Official Journal of the European Union. July 6 2018:26 (https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32018D0945&from=EN#page=26)."},{"key":"e_1_3_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800170"},{"key":"e_1_3_3_2_3_2","unstructured":"Food and Drug Administration. Guidance for industry \u2014 acute bacterial skin and skin structure infections: developing drugs for treatment. October 2013 (http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm071185.pdf)."},{"key":"e_1_3_3_2_4_2","unstructured":"European Medicines Agency. Addendum to the guideline on the evaluation of medical products indicated for treatment of bacterial infections. October 2013 (https:\/\/www.ema.europa.eu\/documents\/scientific-guideline\/addendum-guideline-evaluation-medicinal-products-indicated-treatment-bacterial-infections_en.pdf)."},{"key":"e_1_3_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.05607.x"},{"key":"e_1_4_3_2_2_2","unstructured":"Nuzyra prescribing information. Boston: Paratek Pharmaceuticals 2018 (https:\/\/www.nuzyra.com\/nuzyra-pi.pdf)."},{"key":"e_1_4_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-016-0119-9"},{"key":"e_1_4_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0211-4"},{"key":"e_1_4_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy165"},{"key":"e_1_4_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx163.1415"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMc1903821","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:53:18Z","timestamp":1711500798000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMc1903821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,23]]},"references-count":12,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2019,5,23]]}},"alternative-id":["10.1056\/NEJMc1903821"],"URL":"https:\/\/doi.org\/10.1056\/nejmc1903821","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,23]]}}}